Eradication of Microbial Contamination: How Validated Disinfectants Protect Sterile Manufacturing Kumar Jeetendra | December 8, 2025 India accounts for 60% of the world’s vaccines and 50% of generic medicines. Yet, as the industry is rapidly growing towards a market valuation of $130 billion in 2025, Indian pharmaceutical companies are bracing themselves for unprecedented regulatory scrutiny. The USFDA, MHRA, and EDQM inspections have become increasingly unyielding, while recent production stops due to …
